Fund shareholders of Vertex Pharmaceuticals Inc
ISIN US92532F1003 · United States · LEI 54930015RAQRRZ5ZGJ91
- Fund shareholders
- 1,198
- Of which ETFs
- 310 888 other funds
- Value held
- 56.9B $ 143.7M € · 5.3B SEK
1,198 funds hold this company. This table lists the 1,185 that declare it in a regulatory filing. The other 13 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Growth Fund of America Growth Fund of America | 13,767,050 | 6.8B $ | 2.09 % | as of Feb 28, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 8,069,219 | 3.6B $ | 0.18 % | as of Mar 31, 2026 ↗ |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 6,455,161 | 2.9B $ | 0.20 % | as of Mar 31, 2026 ↗ |
| Investment Co of America Investment Co of America | 6,269,142 | 2.8B $ | 1.69 % | as of Mar 31, 2026 ↗ |
| American Balanced Fund American Balanced Fund | 5,930,918 | 2.6B $ | 1.00 % | as of Mar 31, 2026 ↗ |
| Invesco QQQ Trust, Series 1 Invesco QQQ Trust, Series 1 | 5,351,474 | 2.4B $ | 0.64 % | as of Mar 31, 2026 ↗ |
| AMCAP Fund AMCAP Fund | 4,621,267 | 2.3B $ | 2.45 % | as of Feb 28, 2026 ↗ |
| New Perspective Fund New Perspective Fund | 3,366,011 | 1.5B $ | 0.98 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P 500 ETF iShares Trust | 3,266,609 | 1.5B $ | 0.20 % | as of Mar 31, 2026 ↗ |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 3,228,892 | 1.6B $ | 0.21 % | as of Feb 28, 2026 ↗ |
| VANGUARD GROWTH INDEX FUND VANGUARD INDEX FUNDS | 2,788,745 | 1.2B $ | 0.39 % | as of Mar 31, 2026 ↗ |
| Capital World Growth & Income Fund Capital World Growth & Income Fund | 2,273,163 | 1.1B $ | 0.76 % | as of Feb 28, 2026 ↗ |
| Washington Mutual Investors Fund Washington Mutual Investors Fund | 2,250,814 | 962M $ | 0.45 % | as of Apr 30, 2026 ↗ |
| State Street(R) Health Care Select Sector SPDR(R) ETF SELECT SECTOR SPDR TRUST | 1,848,362 | 825.4M $ | 2.14 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 1,801,919 | 770.1M $ | 2.09 % | as of Apr 30, 2026 ↗ |
| Growth Fund AMERICAN FUNDS INSURANCE SERIES | 1,548,600 | 691.5M $ | 1.39 % | as of Mar 31, 2026 ↗ |
| Growth-Income Fund AMERICAN FUNDS INSURANCE SERIES | 1,464,610 | 654M $ | 1.60 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 1,432,189 | 639.5M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 1,354,033 | 604.6M $ | 7.44 % | as of Mar 31, 2026 ↗ |
| New Economy Fund New Economy Fund | 1,320,751 | 656.2M $ | 1.46 % | as of Feb 28, 2026 ↗ |
| JPMorgan Equity Premium Income ETF J.P. Morgan Exchange-Traded Fund Trust | 1,217,752 | 543.8M $ | 1.24 % | as of Mar 31, 2026 ↗ |
| American Funds Fundamental Investors American Funds Fundamental Investors | 1,161,083 | 518.5M $ | 0.34 % | as of Mar 31, 2026 ↗ |
| Loomis Sayles Growth Fund LOOMIS SAYLES FUNDS II | 1,084,687 | 484.4M $ | 3.02 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 Growth ETF iShares Trust | 1,023,436 | 457M $ | 0.41 % | as of Mar 31, 2026 ↗ |
| Invesco NASDAQ 100 ETF Invesco Exchange-Traded Fund Trust II | 965,197 | 479.5M $ | 0.68 % | as of Feb 28, 2026 ↗ |
| Capital Group Dividend Value ETF Capital Group Dividend Value ETF | 882,131 | 438.3M $ | 1.44 % | as of Feb 28, 2026 ↗ |
| American Funds Global Balanced Fund American Funds Global Balanced Fund | 781,621 | 334M $ | 1.03 % | as of Apr 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 770,119 | 382.6M $ | 1.89 % | as of Feb 28, 2026 ↗ |
| Capital Group Growth ETF Capital Group Growth ETF | 766,745 | 380.9M $ | 1.89 % | as of Feb 28, 2026 ↗ |
| iShares MSCI USA Min Vol Factor ETF iShares Trust | 725,678 | 310.1M $ | 1.36 % | as of Apr 30, 2026 ↗ |
| Harbor Capital Appreciation Fund HARBOR FUNDS | 705,868 | 301.7M $ | 1.19 % | as of Apr 30, 2026 ↗ |
| Asset Allocation Fund AMERICAN FUNDS INSURANCE SERIES | 700,148 | 312.6M $ | 1.19 % | as of Mar 31, 2026 ↗ |
| AB LARGE CAP GROWTH FUND INC AB LARGE CAP GROWTH FUND INC | 687,023 | 293.6M $ | 1.23 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 591,295 | 264M $ | 2.42 % | as of Mar 31, 2026 ↗ |
| Schwab S&P 500 Index Fund SCHWAB CAPITAL TRUST | 563,514 | 240.8M $ | 0.18 % | as of Apr 30, 2026 ↗ |
| JPMorgan U.S. Equity Fund JPMorgan Trust I | 538,530 | 240.5M $ | 0.76 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 500(R) ETF SPDR SERIES TRUST | 533,516 | 238.2M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| JPMorgan Nasdaq Equity Premium Income ETF J.P. Morgan Exchange-Traded Fund Trust | 516,727 | 230.7M $ | 0.67 % | as of Mar 31, 2026 ↗ |
| iShares MSCI USA Quality Factor ETF iShares Trust | 487,125 | 208.2M $ | 0.42 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Large-Cap Growth ETF SCHWAB STRATEGIC TRUST | 486,444 | 241.7M $ | 0.48 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 474,455 | 235.7M $ | 0.19 % | as of Feb 28, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 471,411 | 210.5M $ | 0.13 % | as of Mar 31, 2026 ↗ |
| Columbia Contrarian Core Fund COLUMBIA FUNDS SERIES TRUST I | 465,888 | 231.5M $ | 1.43 % | as of Feb 28, 2026 ↗ |
| ClearBridge Growth Fund Legg Mason Partners Investment Trust | 460,994 | 229M $ | 5.44 % | as of Feb 27, 2026 ↗ |
| ClearBridge Large Cap Growth Fund Legg Mason Partners Investment Trust | 451,929 | 224.5M $ | 2.14 % | as of Feb 27, 2026 ↗ |
| iShares S&P 500 Value ETF iShares Trust | 438,261 | 195.7M $ | 0.42 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 428,684 | 213M $ | 0.23 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 1000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 423,372 | 210.3M $ | 0.45 % | as of Feb 28, 2026 ↗ |
| VANGUARD MEGA CAP GROWTH INDEX FUND VANGUARD WORLD FUND | 404,174 | 180.5M $ | 0.65 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 375,732 | 186.7M $ | 0.19 % | as of Feb 28, 2026 ↗ |
| AP7 Aktiefond Sjunde AP-fonden | 373,609 | 1.6B SEK | 0.12 % | as of Mar 31, 2026 ↗ |
| Edgewood Growth Fund ADVISORS' INNER CIRCLE FUND | 363,370 | 162.3M $ | 2.62 % | as of Mar 31, 2026 ↗ |
| Fidelity Large Cap Growth Index Fund Fidelity Salem Street Trust | 360,949 | 154.3M $ | 0.35 % | as of Apr 30, 2026 ↗ |
| Janus Henderson Balanced Fund JANUS INVESTMENT FUND | 352,635 | 157.5M $ | 0.60 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Research Fund JANUS INVESTMENT FUND | 347,564 | 155.2M $ | 0.63 % | as of Mar 31, 2026 ↗ |
| Invesco S&P 500 Equal Weight ETF Invesco Exchange-Traded Fund Trust | 342,620 | 146.4M $ | 0.17 % | as of Apr 30, 2026 ↗ |
| Capital Group Core Equity ETF Capital Group Core Equity ETF | 342,225 | 170M $ | 1.88 % | as of Feb 28, 2026 ↗ |
| Victory Pioneer Fundamental Growth Fund Victory Portfolios IV | 336,852 | 150.4M $ | 2.60 % | as of Mar 31, 2026 ↗ |
| Victory Pioneer Fund Victory Portfolios IV | 336,481 | 150.3M $ | 1.50 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 318,917 | 142.4M $ | 0.18 % | as of Mar 31, 2026 ↗ |
| VANGUARD U.S. GROWTH FUND VANGUARD WORLD FUND | 310,269 | 154.2M $ | 0.35 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 500(R) Value ETF SPDR SERIES TRUST | 299,078 | 133.6M $ | 0.42 % | as of Mar 31, 2026 ↗ |
| VANGUARD LARGE-CAP INDEX FUND VANGUARD INDEX FUNDS | 298,227 | 133.2M $ | 0.21 % | as of Mar 31, 2026 ↗ |
| Ultra Fund American Century Mutual Funds, Inc. | 275,000 | 117.5M $ | 0.44 % | as of Apr 30, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 273,318 | 135.8M $ | 2.08 % | as of Feb 27, 2026 ↗ |
| Schwab U.S. Large-Cap ETF SCHWAB STRATEGIC TRUST | 261,608 | 130M $ | 0.20 % | as of Feb 28, 2026 ↗ |
| Capital Group Global Growth Equity ETF Capital Group Global Growth Equity ETF | 255,036 | 126.7M $ | 1.34 % | as of Feb 28, 2026 ↗ |
| Bridge Builder Large Cap Growth Fund Bridge Builder Trust | 251,101 | 112.1M $ | 0.43 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND | 239,922 | 107.1M $ | 2.06 % | as of Mar 31, 2026 ↗ |
| Growth Fund American Century Mutual Funds, Inc. | 234,644 | 100.3M $ | 0.68 % | as of Apr 30, 2026 ↗ |
| HARTFORD CORE EQUITY FUND HARTFORD MUTUAL FUNDS, INC | 232,830 | 99.5M $ | 0.87 % | as of Apr 30, 2026 ↗ |
| S&P 500 Index Master Portfolio Master Investment Portfolio | 231,802 | 103.5M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| Global Growth Fund AMERICAN FUNDS INSURANCE SERIES | 223,011 | 99.6M $ | 1.15 % | as of Mar 31, 2026 ↗ |
| ProShares UltraPro QQQ ProShares Trust | 218,188 | 108.4M $ | 0.40 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P U.S. Value ETF iShares Trust | 213,929 | 95.5M $ | 0.40 % | as of Mar 31, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 213,624 | 91.3M $ | 0.16 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 204,873 | 87.6M $ | 0.10 % | as of Apr 30, 2026 ↗ |
| PGIM Jennison Growth Fund Prudential Investment Portfolios, Inc. | 186,437 | 83.3M $ | 1.10 % | as of Mar 31, 2026 ↗ |
| Loomis Sayles Growth Portfolio Brighthouse Funds Trust I | 182,763 | 81.6M $ | 3.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 181,265 | 90.1M $ | 0.11 % | as of Feb 28, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 181,134 | 80.9M $ | 0.19 % | as of Mar 31, 2026 ↗ |
| Columbia Balanced Fund COLUMBIA FUNDS SERIES TRUST I | 177,351 | 88.1M $ | 0.87 % | as of Feb 28, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 174,156 | 77.8M $ | 0.06 % | as of Mar 31, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 173,834 | 77.6M $ | 3.42 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 172,078 | 76.8M $ | 1.03 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Responsible Balanced Account College Retirement Equities Fund | 169,681 | 75.8M $ | 0.37 % | as of Mar 31, 2026 ↗ |
| American Funds Global Insight Fund American Funds Global Insight Fund | 168,441 | 72M $ | 0.35 % | as of Apr 30, 2026 ↗ |
| Lord Abbett Growth Leaders Fund LORD ABBETT SECURITIES TRUST | 160,408 | 68.6M $ | 0.91 % | as of Apr 30, 2026 ↗ |
| iShares Russell Top 200 Growth ETF iShares Trust | 159,031 | 71M $ | 0.48 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Equity Index 500 Fund T. ROWE PRICE INDEX TRUST, INC. | 158,722 | 70.9M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| JPMorgan Hedged Equity Fund JPMorgan Trust I | 157,091 | 70.1M $ | 0.35 % | as of Mar 31, 2026 ↗ |
| JPMorgan Equity Premium Income Fund JPMorgan Trust IV | 155,058 | 69.2M $ | 1.26 % | as of Mar 31, 2026 ↗ |
| Nuveen Large Cap Growth Index Fund TIAA-CREF Funds | 153,138 | 65.4M $ | 0.35 % | as of Apr 30, 2026 ↗ |
| Capital Group Core Balanced ETF Capital Group Core Balanced ETF | 151,330 | 67.6M $ | 1.25 % | as of Mar 31, 2026 ↗ |
| Large Cap Index Master Portfolio Master Investment Portfolio | 150,995 | 67.4M $ | 0.19 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 150,010 | 64.1M $ | 0.16 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 148,507 | 73.8M $ | 0.33 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 147,669 | 73.4M $ | 0.19 % | as of Feb 28, 2026 ↗ |
| JPMorgan Active Value ETF J.P. Morgan Exchange-Traded Fund Trust | 147,401 | 65.8M $ | 1.10 % | as of Mar 31, 2026 ↗ |
| Columbia Cornerstone Growth Fund COLUMBIA FUNDS SERIES TRUST I | 146,039 | 62.4M $ | 0.97 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 9.30 % | as of Feb 28, 2026 ↗ |
| Direxion Daily Biotech Top 5 Bull 2X ETF Direxion Shares ETF Trust | 8.22 % | as of Apr 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 8.06 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 7.44 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 6.27 % | as of Feb 28, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 5.60 % | as of Mar 31, 2026 ↗ |
| ClearBridge Growth Fund Legg Mason Partners Investment Trust | 5.44 % | as of Feb 27, 2026 ↗ |
| ClearBridge Variable Growth Portfolio Legg Mason Partners Variable Equity Trust | 5.33 % | as of Mar 31, 2026 ↗ |
| Virtus KAR Health Sciences Fund Virtus Investment Trust | 5.09 % | as of Mar 31, 2026 ↗ |
| Natixis Loomis Sayles Focused Growth ETF Natixis ETF Trust II | 4.55 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1,048 | +76 | 123,815,099 | +2.9 % |
| 2026Q1 | 972 | -29 | 120,276,157 | +1.8 % |
| 2025Q4 | 1,001 | -22 | 118,183,576 | -3.6 % |
| 2025Q3 | 1,023 | -31 | 122,642,833 | +1.6 % |
| 2025Q2 | 1,054 | +33 | 120,769,763 | +3.2 % |
| 2025Q1 | 1,021 | -78 | 117,052,590 | +2.0 % |
| 2024Q4 | 1,099 | -59 | 114,791,743 | +0.8 % |
| 2024Q3 | 1,158 | -31 | 113,844,744 | +1.6 % |
| 2024Q2 | 1,189 | -2 | 112,003,751 | +5.6 % |
| 2024Q1 | 1,191 | -6 | 106,033,489 | -4.0 % |
| 2023Q4 | 1,197 | 110,442,131 |
Institutional managers
1,670 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Capital World Investors | 25,368,124 | 11.3B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 23,969,517 | 10.7B $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 21,125,964 | 9.4B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 11,730,139 | 5.2B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 7,033,156 | 3.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 6,139,621 | 2.7B $ | as of Mar 31, 2026 |
| Capital International Investors | 5,126,077 | 2.3B $ | as of Mar 31, 2026 |
| LOOMIS SAYLES & CO L P | 4,003,821 | 1.8B $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 3,910,786 | 1.8B $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 3,212,589 | 1.4B $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 3,188,881 | 1.4B $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3,057,396 | 1.4B $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 2,878,183 | 1.3B $ | as of Mar 31, 2026 |
| JENNISON ASSOCIATES LLC | 2,740,059 | 1.2B $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 2,700,975 | 1.2B $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 2,633,481 | 1.2B $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 2,564,264 | 1.1B $ | as of Mar 31, 2026 |
| Invesco Ltd. | 2,561,057 | 1.1B $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,417,875 | 1.1B $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 2,131,527 | 951.8M $ | as of Mar 31, 2026 |
| FMR LLC | 2,020,265 | 902.1M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 1,955,764 | 873.3M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,920,871 | 857.7M $ | as of Mar 31, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | 1,888,521 | 843.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,760,122 | 786K $ | as of Mar 31, 2026 |
Declared shareholders of Vertex Pharmaceuticals Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Capital World Investors | 10.10 % | 25,695,015 | as of Mar 31, 2026 · SCHEDULE 13G |
| Capital Research Global Investors | 8.30 % | 21,139,169 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 7.49 % | 19,036,076 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Vertex Pharmaceuticals Inc". https://titelia.com/en/stocks/vertex-pharmaceuticals-inc-US92532F1003